-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Pro-Dex (NASDAQ:PDEX) Now Covered by Analysts at StockNews.com
Pro-Dex (NASDAQ:PDEX) Now Covered by Analysts at StockNews.com
Research analysts at StockNews.com started coverage on shares of Pro-Dex (NASDAQ:PDEX – Get Rating) in a report released on Monday. The firm set a "buy" rating on the medical instruments supplier's stock.
Pro-Dex Stock Performance
PDEX opened at $17.15 on Monday. The stock's 50 day simple moving average is $16.93 and its 200 day simple moving average is $17.40. The stock has a market cap of $61.40 million, a P/E ratio of 16.49 and a beta of 0.94. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.73 and a quick ratio of 1.39. Pro-Dex has a 1-year low of $12.40 and a 1-year high of $26.50.
Get Pro-Dex alerts:Pro-Dex (NASDAQ:PDEX – Get Rating) last announced its earnings results on Thursday, November 3rd. The medical instruments supplier reported $0.29 EPS for the quarter. The firm had revenue of $11.09 million for the quarter. Pro-Dex had a return on equity of 16.75% and a net margin of 8.97%.
Institutional Investors Weigh In On Pro-Dex
Large investors have recently bought and sold shares of the stock. Tower Research Capital LLC TRC grew its holdings in Pro-Dex by 345.6% during the 3rd quarter. Tower Research Capital LLC TRC now owns 2,687 shares of the medical instruments supplier's stock valued at $48,000 after buying an additional 2,084 shares during the last quarter. Renaissance Technologies LLC acquired a new stake in Pro-Dex during the 2nd quarter valued at $168,000. State Street Corp grew its holdings in Pro-Dex by 5.8% during the 1st quarter. State Street Corp now owns 11,923 shares of the medical instruments supplier's stock valued at $197,000 after buying an additional 650 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in Pro-Dex by 59.2% during the 1st quarter. JPMorgan Chase & Co. now owns 20,863 shares of the medical instruments supplier's stock valued at $345,000 after buying an additional 7,762 shares during the last quarter. Finally, LSV Asset Management grew its holdings in Pro-Dex by 13.9% during the 1st quarter. LSV Asset Management now owns 35,581 shares of the medical instruments supplier's stock valued at $588,000 after buying an additional 4,346 shares during the last quarter. Institutional investors and hedge funds own 13.49% of the company's stock.About Pro-Dex
(Get Rating)
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Recommended Stories
- Get a free copy of the StockNews.com research report on Pro-Dex (PDEX)
- General Electric Stock, The Sum of All Parts Strategy is Paying Off
- MarketBeat: Week in Review 01/09-01/13
- JPMorgan Chase Falls As Banks Brace For Recession
- Why is the Bed Bath & Beyond Stock Price up 261%?
- Roku Stock Price is Trending, Here's Why
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.
StockNews.com的研究分析师开始报道Pro-Dex(纳斯达克:PDEX-GET评级)在周一发布的一份报告中。该公司对这家医疗器械供应商的库存设定了“买入”评级。
Pro-Dex股票表现
PDEX周一开盘报17.15美元。该股的50日简单移动均线切入位为16.93美元,200日简单移动均线切入位为17.40美元。该股市值为6140万美元,市盈率为16.49倍,贝塔系数为0.94。该公司的债务权益比为0.41,流动比率为2.73,速动比率为1.39。Pro-Dex的一年低点为12.40美元,一年高位为26.50美元。
到达支持Dex警报:Pro-Dex(纳斯达克:PDEX-GET Rating)最近一次公布盈利业绩是在11月3日(星期四)。这家医疗器械供应商公布本季度每股收益为0.29美元。该公司本季度的收入为1109万美元。Pro-Dex的股本回报率为16.75%,净利润率为8.97%。
机构投资者参与Pro-Dex
大型投资者最近买卖了该股的股票。Tower Research Capital LLC TRC在第三季度增持了Pro-Dex 345.6%的股份。Tower Research Capital LLC TRC在上个季度额外购买了2,084股后,现在拥有这家医疗器械供应商2,687股股票,价值48,000美元。复兴技术有限责任公司在第二季度收购了Pro-Dex的新股份,价值16.8万美元。道富集团在第一季度持有的Pro-Dex股票增加了5.8%。道富集团目前持有这家医疗器械供应商11,923股股票,价值19.7万美元,此前该公司在上个季度又购买了650股。摩根大通第一季度对Pro-Dex的持有量增加了59.2%。摩根大通(JPMorgan Chase&Co.)目前持有这家医疗器械供应商20,863股股票,价值345,000美元,上一季度又购买了7,762股。最后,LSV Asset Management在第一季度增持了Pro-Dex 13.9%的股份。LSV资产管理公司现在拥有这家医疗器械供应商的35,581股股票,价值58.8万美元,上个季度又购买了4,346股。机构投资者和对冲基金持有该公司13.49%的股票。关于Pro-Dex
(获取评级)
Pro-Dex公司为世界各地的医疗器械原始设备制造商设计、开发、制造和销售动力手术器械。该公司提供可高压灭菌、电池供电和电动的多功能外科驱动程序和剃须刀,主要用于整形外科、胸部和颅颌面部市场。
推荐故事
- 免费获取StockNews.com Pro-Dex上的研究报告(PDEX)
- 通用电气股票,所有部件的总和战略正在奏效
- MarketBeat:回顾中的一周01/09-01/13
- 摩根大通破产,银行为衰退做好准备
- 为什么Bed Bath&Beyond的股价上涨了261%?
- Roku股价走势,原因如下
接受Pro-Dex Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Pro-Dex和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧